SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Mimedx Group, Inc. – ‘10-K’ for 12/31/21 – ‘EX-32.1’

On:  Monday, 2/28/22, at 5:11pm ET   ·   For:  12/31/21   ·   Accession #:  1376339-22-7   ·   File #:  1-35887

Previous ‘10-K’:  ‘10-K’ on 3/8/21 for 12/31/20   ·   Next:  ‘10-K’ on 2/28/23 for 12/31/22   ·   Latest:  ‘10-K’ on 2/28/24 for 12/31/23   ·   26 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/28/22  Mimedx Group, Inc.                10-K       12/31/21  112:13M

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.42M 
 3: EX-10.38    Material Contract                                   HTML    739K 
 2: EX-10.6     Material Contract                                   HTML     40K 
 4: EX-21.1     Subsidiaries List                                   HTML     28K 
 5: EX-23.1     Consent of Expert or Counsel                        HTML     28K 
 6: EX-23.2     Consent of Expert or Counsel                        HTML     28K 
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     32K 
 8: EX-31.2     Certification -- §302 - SOA'02                      HTML     32K 
 9: EX-32.1     Certification -- §906 - SOA'02                      HTML     30K 
10: EX-32.2     Certification -- §906 - SOA'02                      HTML     30K 
16: R1          Cover Page                                          HTML     92K 
17: R2          Audit Information                                   HTML     33K 
18: R3          Consolidated Balance Sheets                         HTML    137K 
19: R4          Consolidated Balance Sheets (Parenthetical)         HTML     62K 
20: R5          Consolidated Statements of Operations               HTML    114K 
21: R6          Consolidated Statements of Stockholders? Equity     HTML    101K 
                (Deficit)                                                        
22: R7          Consolidated Statements of Cash Flows               HTML    130K 
23: R8          Nature of Business                                  HTML     42K 
24: R9          Significant Accounting Policies                     HTML    109K 
25: R10         Accounts Receivable, Net                            HTML     36K 
26: R11         Inventory                                           HTML     38K 
27: R12         Property and Equipment                              HTML     52K 
28: R13         Leases                                              HTML    130K 
29: R14         Goodwill and Intangible Assets                      HTML     75K 
30: R15         Accrued Expenses                                    HTML     41K 
31: R16         Long Term Debt                                      HTML    100K 
32: R17         Net Loss Per Common Share                           HTML     71K 
33: R18         Equity                                              HTML    103K 
34: R19         Income Taxes                                        HTML    111K 
35: R20         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     47K 
                Investing and Financing Activities                               
36: R21         401(k) Plan                                         HTML     35K 
37: R22         Commitments and Contingencies                       HTML     48K 
38: R23         Revenue                                             HTML     53K 
39: R24         Related Party Transactions                          HTML     32K 
40: R25         Restructuring                                       HTML     39K 
41: R26         Subsequent Events                                   HTML     30K 
42: R27         Schedule II Valuation and Qualifying Accounts       HTML     52K 
43: R28         Significant Accounting Policies (Policies)          HTML    165K 
44: R29         Significant Accounting Policies (Tables)            HTML     54K 
45: R30         Accounts Receivable, Net (Tables)                   HTML     36K 
46: R31         Inventory (Tables)                                  HTML     38K 
47: R32         Property and Equipment (Tables)                     HTML     53K 
48: R33         Leases (Tables)                                     HTML     81K 
49: R34         Goodwill and Intangible Assets (Tables)             HTML    107K 
50: R35         Accrued Expenses (Tables)                           HTML     40K 
51: R36         Long Term Debt (Tables)                             HTML     80K 
52: R37         Basic and Diluted Net Loss Per Common Share         HTML     75K 
                (Tables)                                                         
53: R38         Equity (Tables)                                     HTML     96K 
54: R39         Income Taxes (Tables)                               HTML    108K 
55: R40         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     47K 
                Investing and Financing Activities (Tables)                      
56: R41         Commitments and Contingencies (Tables)              HTML     33K 
57: R42         Revenue (Tables)                                    HTML     66K 
58: R43         Restructuring (Tables)                              HTML     36K 
59: R44         Nature of Business (Details)                        HTML     62K 
60: R45         Significant Accounting Policies - Additional        HTML     65K 
                Information (Details)                                            
61: R46         Significant Accounting Policies - Transition        HTML     59K 
                Adjustment and Cash Collections on Remaining                     
                Contracts (Details)                                              
62: R47         Accounts Receivable, Net (Details)                  HTML     36K 
63: R48         Inventory (Details)                                 HTML     46K 
64: R49         Property and Equipment - Property and Equipment     HTML     52K 
                (Details)                                                        
65: R50         Property and Equipment - Depreciation (Details)     HTML     37K 
66: R51         Leases - Narrative (Details)                        HTML     34K 
67: R52         Leases - Supplemental Balance Sheet Information     HTML     72K 
                (Details)                                                        
68: R53         Leases - Lease Costs (Details)                      HTML     36K 
69: R54         Leases - Maturity of Lease Liabilities (Details)    HTML     86K 
70: R55         Goodwill and Intangible Assets - Narrative          HTML     33K 
                (Details)                                                        
71: R56         Goodwill and Intangible Assets - Changes in         HTML     33K 
                Carrying Amount of Goodwill (Details)                            
72: R57         Goodwill and Intangible Assets - Activity Summary   HTML     59K 
                (Details)                                                        
73: R58         Goodwill and Intangible Assets - Amortization       HTML     33K 
                Expense (Details)                                                
74: R59         Goodwill and Intangible Assets - Expected Future    HTML     44K 
                Amortization of Intangible Assets (Details)                      
75: R60         Accrued Expenses (Details)                          HTML     48K 
76: R61         Long Term Debt - Term Loan (Details)                HTML    127K 
77: R62         Long Term Debt - Term Loan Debt Issuance Costs      HTML     44K 
                (Details)                                                        
78: R63         Long Term Debt - Term Loan Balances (Details)       HTML     43K 
79: R64         Long Term Debt - Term Loan Interest Expense         HTML     52K 
                (Details)                                                        
80: R65         Long Term Debt - Term Loan Maturity (Details)       HTML     49K 
81: R66         Long Term Debt - Term Loan Extinguishment of Debt   HTML     44K 
                (Details)                                                        
82: R67         Basic and Diluted Net Loss Per Common Share -       HTML     64K 
                Basic Net Loss Per Common Share (Details)                        
83: R68         Basic and Diluted Net Loss Per Common Share -       HTML     63K 
                Diluted Net Loss Per Common Share (Details)                      
84: R69         Equity - Convertible Preferred Stock Series B       HTML     62K 
                (Details)                                                        
85: R70         Equity - Changes in Series B Preferred Stock        HTML     45K 
                (Details)                                                        
86: R71         Equity - Stock Incentive Plans (Details)            HTML     57K 
87: R72         Equity - Stock Option Activity (Details)            HTML     70K 
88: R73         Equity - Modification of Stock Options (Details)    HTML     63K 
89: R74         Equity - Restricted Stock Awards (Details)          HTML     57K 
90: R75         Equity - Summary of Restricted Stock Awards         HTML     65K 
                (Details)                                                        
91: R76         Equity - Recognized Stock-Based Compensation        HTML     42K 
                (Details)                                                        
92: R77         Equity - Treasury Stock (Details)                   HTML     37K 
93: R78         Income Taxes - Narrative (Details)                  HTML     74K 
94: R79         Income Taxes - Deferred Tax Assets and Liabilities  HTML     72K 
                (Details)                                                        
95: R80         Income Taxes - Reconciliation of the Federal        HTML     58K 
                Statutory Income Tax (Details)                                   
96: R81         Income Taxes - Schedule of current and deferred     HTML     51K 
                income tax expense (Benefit) (Details)                           
97: R82         Income Taxes - Reconciliation of unrecognized tax   HTML     36K 
                benefits (Details)                                               
98: R83         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     54K 
                Investing and Financing Activities (Details)                     
99: R84         401(k) Plan (Details)                               HTML     44K 
100: R85         Commitments and Contingencies - Narrative           HTML     40K  
                (Details)                                                        
101: R86         Commitments and Contingencies - Estimated Annual    HTML     35K  
                Lease, Royalty, and Employment Agreement Expenses                
                (Details)                                                        
102: R87         Revenue - Summary of Revenue by Product Type        HTML     48K  
                (Details)                                                        
103: R88         Revenue - Summary of Revenue by Customer Type       HTML     42K  
                (Details)                                                        
104: R89         Related Party Transactions (Details)                HTML     41K  
105: R90         Restructuring - Narrative (Details)                 HTML     35K  
106: R91         Restructuring - Restructuring Reserve Liability     HTML     36K  
                (Details)                                                        
107: R92         Schedule II Valuation and Qualifying Accounts       HTML     40K  
                (Details)                                                        
110: XML         IDEA XML File -- Filing Summary                      XML    197K  
108: XML         XBRL Instance -- mdxg-20211231_htm                   XML   2.72M  
109: EXCEL       IDEA Workbook of Financial Reports                  XLSX    143K  
12: EX-101.CAL  XBRL Calculations -- mdxg-20211231_cal               XML    333K 
13: EX-101.DEF  XBRL Definitions -- mdxg-20211231_def                XML    668K 
14: EX-101.LAB  XBRL Labels -- mdxg-20211231_lab                     XML   2.20M 
15: EX-101.PRE  XBRL Presentations -- mdxg-20211231_pre              XML   1.31M 
11: EX-101.SCH  XBRL Schema -- mdxg-20211231                         XSD    216K 
111: JSON        XBRL Instance as JSON Data -- MetaLinks              524±   749K  
112: ZIP         XBRL Zipped Folder -- 0001376339-22-000007-xbrl      Zip    653K

‘EX-32.1’   —   Certification — §906 – SOA’02

This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]

 <!   C:   C: 
  Document  

Exhibit 32.1
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
    The undersigned Timothy R. Wright, the Chief Executive Officer of MiMedx Group, Inc. (the “Company”), has executed this certification in connection with the filing with the Securities and Exchange Commission of the Company’s Annual Report on Form 10-K for the period ending December 31, 2021 (the “Report”). Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned hereby certifies, to his knowledge, that:

(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date:February 28, 2022/s/ Timothy R. Wright
 Timothy R. Wright
 Chief Executive Officer


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/28/224,  8-K
For Period end:12/31/21
 List all Filings 

4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/24  Mimedx Group, Inc.                10-K       12/31/23  116:11M
 2/28/23  Mimedx Group, Inc.                10-K       12/31/22  123:13M
 6/17/22  Mimedx Group, Inc.                S-8         6/17/22    5:85K                                    Donnelley … Solutions/FA
 5/03/22  Mimedx Group, Inc.                10-Q        3/31/22   71:5.5M

22 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/03/21  Mimedx Group, Inc.                10-Q        6/30/21   77:7.4M
 6/10/21  Mimedx Group, Inc.                8-K:5,9     6/09/21   12:193K
 6/03/21  Mimedx Group, Inc.                8-K:5,9     5/27/21   11:244K
 4/21/21  Mimedx Group, Inc.                8-K:5,9     4/19/21   12:465K                                   Donnelley … Solutions/FA
 3/30/21  Mimedx Group, Inc.                8-K:4,9     3/25/21   13:178K
 3/08/21  Mimedx Group, Inc.                10-K       12/31/20  111:12M
12/21/20  Mimedx Group, Inc.                8-K:5      12/16/20   14:372K
12/17/20  Mimedx Group, Inc.                S-8        12/17/20    5:422K                                   Donnelley … Solutions/FA
11/04/20  Mimedx Group, Inc.                10-Q        9/30/20   79:7.4M
11/02/20  Mimedx Group, Inc.                8-A12B                 1:37K
 7/06/20  Mimedx Group, Inc.                10-K       12/31/19  119:16M
 3/17/20  Mimedx Group, Inc.                10-K       12/31/18  111:16M
 5/30/19  Mimedx Group, Inc.                8-K:8,9     5/30/19   11:511K                                   Donnelley … Solutions/FA
 5/09/19  Mimedx Group, Inc.                8-K:5,7,9   5/06/19    3:112K                                   Donnelley … Solutions/FA
 3/13/17  Mimedx Group, Inc.                8-K:1,2,9   3/07/17    2:81K
 8/02/16  Mimedx Group, Inc.                10-Q        6/30/16   72:5.6M
 3/04/14  Mimedx Group, Inc.                10-K       12/31/13   81:10M
 3/03/14  Mimedx Group, Inc.                8-K:1,5,9   2/25/14    3:187K                                   Broadridge Fin’l So… Inc
 8/08/13  Mimedx Group, Inc.                10-Q        6/30/13  104:10M
 5/10/13  Mimedx Group, Inc.                10-Q        3/31/13   60:6M                                     Broadridge Fin’l So… Inc
 7/15/08  Mimedx Group, Inc.                8-K:1,5,9   7/09/08    3:85K                                    Bowne - BPC/FA
 2/08/08  Mimedx Group, Inc.                8-K:1,2,3,4 2/08/08   63:3.9M                                   Donnelley … Solutions/FA
↑Top
Filing Submission 0001376339-22-000007   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., May 17, 11:04:07.4am ET